Jennifer Cote - 29 Dec 2023 Form 4 Insider Report for HARVARD BIOSCIENCE INC (HBIO)

Role: Chief Financial Officer, Director
Signature: /s/ David Sirois, by power of attorney
Issuer symbol: HBIO
Transactions as of: 29 Dec 2023
Net transactions value: -$31,618
Form type: 4
Filing time: 03 Jan 2024, 17:17:24 UTC
Previous filing: 08 Mar 2023
Next filing: 07 Mar 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HBIO	Common Stock	Tax liability	$17,543	-3,279	-2.9%	$5.35	109,689	29 Dec 2023	Direct	F1
transaction	HBIO	Common Stock	Tax liability	$14,076	-2,631	-2.4%	$5.35	107,058	29 Dec 2023	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with restricted stock unit awards previously granted to the reporting person that vested in part on December 29, 2023.
F2	Includes (a) 17,928 restricted stock units that will vest in two equal installments on December 29, 2024 and 2025, (b) 11,171 restricted stock units that will vest on December 29, 2024, (c) 25,862 restricted stock units with performance based vesting conditions tied to relative total shareholder return, (d) 29,880 restricted stock units that will vest on March 6, 2024 and (e) 22,217 shares of common stock beneficially owned by the Reporting Person.

Content

The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with restricted stock unit awards previously granted to the reporting person that vested in part on December 29, 2023.

Includes (a) 17,928 restricted stock units that will vest in two equal installments on December 29, 2024 and 2025, (b) 11,171 restricted stock units that will vest on December 29, 2024, (c) 25,862 restricted stock units with performance based vesting conditions tied to relative total shareholder return, (d) 29,880 restricted stock units that will vest on March 6, 2024 and (e) 22,217 shares of common stock beneficially owned by the Reporting Person.